Application of the Scleroderma Clinical Trials Consortium Damage Index in patients with juvenile systemic sclerosis
There are differences in clinical presentations between adult SSc patients and jSSc patients. The SCTC-DI can be applied to JSSc patients, and it is recommended that JSSc patients undergo regular evaluations of the J4S as well as the SCTC-DI.
Authors
- Hongzhong Jin (ORCID: https://orcid.org/0000-0001-6234-1554)
- Caihui Zhang
- Hongmei Song (ORCID: https://orcid.org/0000-0001-9801-2517)
- Sihao Gao (ORCID: https://orcid.org/0000-0001-8839-2982)
- Wei Wang (ORCID: https://orcid.org/0000-0003-3836-5462)
- Lin Wang (ORCID: https://orcid.org/0000-0002-7182-9356)
- Tianyu Zhang (ORCID: https://orcid.org/0000-0003-2745-4216)
- Yu Zhang (ORCID: https://orcid.org/0000-0002-7690-3172)
- Li Zhuo (ORCID: https://orcid.org/0000-0003-2028-6168)
- Xiaoyan Tang (ORCID: https://orcid.org/0000-0001-5171-3025)
- Zhixing Sun
- Xiaofeng Zeng (ORCID: https://orcid.org/0000-0001-9484-8093)
- Mingsheng Ma (ORCID: https://orcid.org/0000-0003-4485-2945)
- Changyan Wang
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking Union Medical College Hospital (CN)
Publication Details
- Journal
- Pediatric Rheumatology
- Published
- 2025-05-14
- DOI
- https://doi.org/10.1186/s12969-025-01110-6
- Citations
- 2
- Primary Topic
- Systemic Sclerosis and Related Diseases
- Type
- article
- Field-Weighted Citation Impact
- 2.94
Funders
- Peking Union Medical College Hospital
- National Key Research and Development Program of China
- High-level Hospital Construction Project of Guangdong Provincial People's Hospital